VERY TALL CHILDREN HAVE SIMILRR 24H-GH LEVELS AS SHORT CHILDREN BW HIGHER CIRCULATING INSULIN AND LESS IGFBP-1
The amount o f and/or the p a t t e r n o f growth h o m n e s e c r e t i o n i s g e n e r a l l y m n s i d e r e d t o be t h e main r e g u l a t o r o f l i n e a r growth. SpOntaneouS GH, i n s u l i n a n d IGf'BP-1, and IGF-I l e v e l s were t h e r e f o r e i n v e s t i g a t e d i n v e r y t a l l c h i l d r e n and compared w i t h t h o s e o f p r e p u b e r t a l s h o r t c h i l d r e n w i t h c o n s t i t u t i o n a l d e l a y o f g r o w t h and a d o l e s c e n c e . Data is g i v e n as mean (SEM).
T a l l c h i l d r e n Short c h i l d r e n n-18 Age y r 8.410.5) 1 2 . 7 ( 0 . 7 ) 9 . 6 ( 0 . 7 ) H e i g h t SD 3 . 7 ( 0 . 3 ) 3 . 2 ( 0 . 1 ) -2 . 6 ( 0 . 2 ) GV cm/yr Bone a g e SD BMI ku/m2 2 4 h /~~-m e a n pg/L 1 . 1 . 
S k c l c t n l d y s p l a s l o often r o s u l t s !I, severe s h o r t s t a t u r e . 'rllls Ims t r a d i t i o n a l l y n o t been thouglit t o respond t o GI1 t r e a t i i~e n t . we h e r e r e p o r t t h e f i r s t y e a r growtl, r e s p o n s e t o GI1 t r e a t m e n t of a g r o u p o f c h i l d r e n w i t h achondro-o r h y p o c h o n d r o p l n s i a . I n c l u s i o n c r i t e r i a : H e i g h t < -2S0

a o n t l i s UE GI1 t r e a t n l c n t g i v e s a s i g n l f l c a i i t incrensc --i n growth v e l o c i t y w i t h o u t worsening body d i s p r o p o r t i o n s i n c l , i l d r m w i t h a c h o n d r o p l a s i a or Ily-hondroplasia.
No major d l f f o r e r i c e was seen between t h e GI1 d o s e s 0.1 or 0 . 2 U/kg 220 GROWTH IIORHONE TREATHWT IN PFADER-LRBAFlTHUILLI SYNDROME O.Tryg~tad,Endocr.UnIt,Ped.de~t.,Natlanal hosPital,Univ.af 0slo.N-0027 Oslo 6 D.Veimo, Ped.dept.,Nordland Centr.Hosplta1 lUIT1, N-8017 Bods, Norway.
Thc P-L-W syndrome i s assumed to be caused by h~pothalamlc dysfunction. Patients bave iricreascd ~ppetlte,severc~beSlty.dlStUrbed pubertal development and growth retardation,reduced sensitlvlty for paln,d!sturbed body tcnperatur regulation and muscular hypotonia. Tlils study i s performed on prepubertal boys and g l r l s above 4 years of age with rctardcd IIA and sutflcicnt energy Intake. Diagnosis was based on clinical signs arid maryotype. Crorlh hormone therapy was suqgcsted to bc lrerieflcial and the objectives were to study the e f f e c t s of therapy on musc~~lnr maes,fat nobillsation and t h e stlnulation of growth. The prellmlnary data from 6 p.ltients are presented in t h e table. hcll dosage 0.1 IU/kg/d, max.4lU/d, glven 7 d/v. The result i s a great effect on growth, cxpresscd as an increase In HV and ll-SDS, a rcductlon In f a t expressend in % lFutrex -Infrared refr.of s.c.fat1 and fattmuscle ratlo In the thiqh (CT scan).
Conclusion: hcll therapy o f f e r s a great beneficial e f f e c t on grouth, body velgbt and complsltlon in P-L-W patients. Famllles and teachers also experiences a clear Improvement in scool performance and psychoaoclal adjustment. Patients have normal height p a r e n t s , exhibit extreme short stature ( H t s -4 to -5 S D S ) , absent to low responses to GH stimulation t e s t s , no response to GHRH stimulation and low levels of IGF-blnding proteins. They responded well to GH therapy and did not develop antibodies to GH. We used a two stage PCR strategy to study GH-1 g d n e s in two of the families. Amplification of a 2.2 kb G H -1 gene fragment from each specimen excluded IGHD IA ( G H -1 gene deletion). The second round of PCR amplified 500 bp of GH-1 promoter sequence for SSCP a n a l y s i s , a
